September 27, 2010 — Certain lots of epoetin alfa (Epogen and Procrit; Amgen) vials are being recalled because they may contain lamellae (extremely thin, barely visible glass flakes), the US Food and ...

Amgen Inc. and Johnson & Johnson recalled certain lots of the anemia drugs Epogen and Procrit that may be contaminated with glass shards that flake off vials into the medicines. The “extremely thin ...

THOUSAND OAKS, Calif., Sept. 24 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty ...

NEW BRUNSWICK, N.J. Johnson & Johnson’s subsidiary Ortho Biotech is recalling more than 44,000 vials of the erythropoiesis-stimulating agent Procrit because its post-manufacturing inspection found ...

June 13, 2002 — Certain lots of epoetin alfa (Procrit) may be ineffective, according to a notice posted on the US Food and Drug Administration MedWatch Web site. The drug's manufacturer, Ortho Biotech ...

Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes ...

Anemia drugs Procrit and Epogen interact with glass vials over time to produce glass flakes, and that has led to an Amgen recall of the parenteral. The recalled lots were old, and the glass flakes, ...

Drug-makers Amgen (AMGN) and Johnson & Johnson (JNJ) are voluntarily recalling two brands of an injectable anemia medication because vials containing the drug may have tiny glass flakes. The drug, ...

Hospitals and pharmacies may have unknowingly bought a counterfeit version of the anti-anemia drug Procrit — and the useless product also is contaminated with bacteria, the government warned Tuesday.